Altered iron and myelin in premanifest Huntington's Disease more than 20 years before clinical onset: Evidence from the cross-sectional HD Young Adult Study

Background: Pathological processes in Huntington's disease (HD) begin many years prior to symptom onset. Recently we demonstrated that in a premanifest cohort approximately 24 years from predicted disease onset, despite intact function, there was evidence of subtle neurodegeneration. Here, we u...

Full description

Bibliographic Details
Main Authors: Eileanoir B. Johnson, Christopher S. Parker, Rachael I. Scahill, Sarah Gregory, Marina Papoutsi, Paul Zeun, Katherine Osborne-Crowley, Jessica Lowe, Akshay Nair, Carlos Estevez-Fraga, Kate Fayer, Geraint Rees, Hui Zhang, Sarah J. Tabrizi
Format: Article
Language:English
Published: Elsevier 2021-03-01
Series:EBioMedicine
Subjects:
MRI
Online Access:http://www.sciencedirect.com/science/article/pii/S2352396421000591
id doaj-a5b119aef0874e58add8c97f8d4a0310
record_format Article
collection DOAJ
language English
format Article
sources DOAJ
author Eileanoir B. Johnson
Christopher S. Parker
Rachael I. Scahill
Sarah Gregory
Marina Papoutsi
Paul Zeun
Katherine Osborne-Crowley
Jessica Lowe
Akshay Nair
Carlos Estevez-Fraga
Kate Fayer
Geraint Rees
Hui Zhang
Sarah J. Tabrizi
spellingShingle Eileanoir B. Johnson
Christopher S. Parker
Rachael I. Scahill
Sarah Gregory
Marina Papoutsi
Paul Zeun
Katherine Osborne-Crowley
Jessica Lowe
Akshay Nair
Carlos Estevez-Fraga
Kate Fayer
Geraint Rees
Hui Zhang
Sarah J. Tabrizi
Altered iron and myelin in premanifest Huntington's Disease more than 20 years before clinical onset: Evidence from the cross-sectional HD Young Adult Study
EBioMedicine
Huntington's disease
MRI
Microstructure
Iron
Myelin
author_facet Eileanoir B. Johnson
Christopher S. Parker
Rachael I. Scahill
Sarah Gregory
Marina Papoutsi
Paul Zeun
Katherine Osborne-Crowley
Jessica Lowe
Akshay Nair
Carlos Estevez-Fraga
Kate Fayer
Geraint Rees
Hui Zhang
Sarah J. Tabrizi
author_sort Eileanoir B. Johnson
title Altered iron and myelin in premanifest Huntington's Disease more than 20 years before clinical onset: Evidence from the cross-sectional HD Young Adult Study
title_short Altered iron and myelin in premanifest Huntington's Disease more than 20 years before clinical onset: Evidence from the cross-sectional HD Young Adult Study
title_full Altered iron and myelin in premanifest Huntington's Disease more than 20 years before clinical onset: Evidence from the cross-sectional HD Young Adult Study
title_fullStr Altered iron and myelin in premanifest Huntington's Disease more than 20 years before clinical onset: Evidence from the cross-sectional HD Young Adult Study
title_full_unstemmed Altered iron and myelin in premanifest Huntington's Disease more than 20 years before clinical onset: Evidence from the cross-sectional HD Young Adult Study
title_sort altered iron and myelin in premanifest huntington's disease more than 20 years before clinical onset: evidence from the cross-sectional hd young adult study
publisher Elsevier
series EBioMedicine
issn 2352-3964
publishDate 2021-03-01
description Background: Pathological processes in Huntington's disease (HD) begin many years prior to symptom onset. Recently we demonstrated that in a premanifest cohort approximately 24 years from predicted disease onset, despite intact function, there was evidence of subtle neurodegeneration. Here, we use novel imaging techniques to determine whether macro- and micro-structural changes can be detected across the whole-brain in the same cohort. Methods: 62 premanifest HD (PreHD) and 61 controls from the HD Young Adult Study (HD-YAS) were included. Grey and white matter volume, diffusion weighted imaging (DWI) measures of white matter microstructure, multiparametric maps (MPM) estimating myelin and iron content from magnetization transfer (MT), proton density (PD), longitudinal relaxation (R1) and effective transverse relaxation (R2*), and myelin g-ratio were examined. Group differences between PreHD and controls were assessed; associations between all imaging metrics and disease burden and CSF neurofilament light (NfL) were also performed. Volumetric and MPM results were corrected at a cluster-wise value of familywise error (FWE) 0.05. Diffusion and g-ratio results were corrected via threshold-free cluster enhancement at FWE 0.05. Findings: We showed significantly increased R1 and R2*, suggestive of increased iron, in the putamen, globus pallidum and external capsule of PreHD participants. There was also a significant association between lower cortical R2*, suggestive of reduced myelin or iron, and higher CSF NfL in the frontal lobe and the parieto-occipital cortices. No other results were significant at corrected levels. Interpretation: Increased iron in subcortical structures and the surrounding white matter is a feature of very early PreHD. Furthermore, increases in CSF NfL were linked to microstructural changes in the posterior parietal-occipital cortex, a region previously shown to undergo some of the earliest cortical changes in HD. These findings suggest that disease related process are occurring in both subcortical and cortical regions more than 20 years from predicted disease onset.
topic Huntington's disease
MRI
Microstructure
Iron
Myelin
url http://www.sciencedirect.com/science/article/pii/S2352396421000591
work_keys_str_mv AT eileanoirbjohnson alteredironandmyelininpremanifesthuntingtonsdiseasemorethan20yearsbeforeclinicalonsetevidencefromthecrosssectionalhdyoungadultstudy
AT christophersparker alteredironandmyelininpremanifesthuntingtonsdiseasemorethan20yearsbeforeclinicalonsetevidencefromthecrosssectionalhdyoungadultstudy
AT rachaeliscahill alteredironandmyelininpremanifesthuntingtonsdiseasemorethan20yearsbeforeclinicalonsetevidencefromthecrosssectionalhdyoungadultstudy
AT sarahgregory alteredironandmyelininpremanifesthuntingtonsdiseasemorethan20yearsbeforeclinicalonsetevidencefromthecrosssectionalhdyoungadultstudy
AT marinapapoutsi alteredironandmyelininpremanifesthuntingtonsdiseasemorethan20yearsbeforeclinicalonsetevidencefromthecrosssectionalhdyoungadultstudy
AT paulzeun alteredironandmyelininpremanifesthuntingtonsdiseasemorethan20yearsbeforeclinicalonsetevidencefromthecrosssectionalhdyoungadultstudy
AT katherineosbornecrowley alteredironandmyelininpremanifesthuntingtonsdiseasemorethan20yearsbeforeclinicalonsetevidencefromthecrosssectionalhdyoungadultstudy
AT jessicalowe alteredironandmyelininpremanifesthuntingtonsdiseasemorethan20yearsbeforeclinicalonsetevidencefromthecrosssectionalhdyoungadultstudy
AT akshaynair alteredironandmyelininpremanifesthuntingtonsdiseasemorethan20yearsbeforeclinicalonsetevidencefromthecrosssectionalhdyoungadultstudy
AT carlosestevezfraga alteredironandmyelininpremanifesthuntingtonsdiseasemorethan20yearsbeforeclinicalonsetevidencefromthecrosssectionalhdyoungadultstudy
AT katefayer alteredironandmyelininpremanifesthuntingtonsdiseasemorethan20yearsbeforeclinicalonsetevidencefromthecrosssectionalhdyoungadultstudy
AT geraintrees alteredironandmyelininpremanifesthuntingtonsdiseasemorethan20yearsbeforeclinicalonsetevidencefromthecrosssectionalhdyoungadultstudy
AT huizhang alteredironandmyelininpremanifesthuntingtonsdiseasemorethan20yearsbeforeclinicalonsetevidencefromthecrosssectionalhdyoungadultstudy
AT sarahjtabrizi alteredironandmyelininpremanifesthuntingtonsdiseasemorethan20yearsbeforeclinicalonsetevidencefromthecrosssectionalhdyoungadultstudy
_version_ 1724226050898001920
spelling doaj-a5b119aef0874e58add8c97f8d4a03102021-03-11T04:25:24ZengElsevierEBioMedicine2352-39642021-03-0165103266Altered iron and myelin in premanifest Huntington's Disease more than 20 years before clinical onset: Evidence from the cross-sectional HD Young Adult StudyEileanoir B. Johnson0Christopher S. Parker1Rachael I. Scahill2Sarah Gregory3Marina Papoutsi4Paul Zeun5Katherine Osborne-Crowley6Jessica Lowe7Akshay Nair8Carlos Estevez-Fraga9Kate Fayer10Geraint Rees11Hui Zhang12Sarah J. Tabrizi13Huntington's Disease Centre, Department of Neurodegenerative disease, UCL Queen Square Institute of Neurology, University College London, London, UK; Corresponding author.Centre for Medical Image Computing, Department of Computer Science, UCL, London, UKHuntington's Disease Centre, Department of Neurodegenerative disease, UCL Queen Square Institute of Neurology, University College London, London, UKHuntington's Disease Centre, Department of Neurodegenerative disease, UCL Queen Square Institute of Neurology, University College London, London, UKHuntington's Disease Centre, Department of Neurodegenerative disease, UCL Queen Square Institute of Neurology, University College London, London, UK; IXICO Plc, London, , UKHuntington's Disease Centre, Department of Neurodegenerative disease, UCL Queen Square Institute of Neurology, University College London, London, UKDivision of Equity, Diversity and Inclusion, University of New South Wales, Sydney, New South Wales, AustraliaHuntington's Disease Centre, Department of Neurodegenerative disease, UCL Queen Square Institute of Neurology, University College London, London, UKHuntington's Disease Centre, Department of Neurodegenerative disease, UCL Queen Square Institute of Neurology, University College London, London, UK; Max Planck University College London Centre for Computational Psychiatry and Ageing Research, UCL Queen Square Institute of Neurology, London, UKHuntington's Disease Centre, Department of Neurodegenerative disease, UCL Queen Square Institute of Neurology, University College London, London, UKHuntington's Disease Centre, Department of Neurodegenerative disease, UCL Queen Square Institute of Neurology, University College London, London, UKUniversity College London Institute of Cognitive Neuroscience, University College London, London, UKCentre for Medical Image Computing, Department of Computer Science, UCL, London, UKHuntington's Disease Centre, Department of Neurodegenerative disease, UCL Queen Square Institute of Neurology, University College London, London, UK; Dementia Research Institute at University College London, London, UKBackground: Pathological processes in Huntington's disease (HD) begin many years prior to symptom onset. Recently we demonstrated that in a premanifest cohort approximately 24 years from predicted disease onset, despite intact function, there was evidence of subtle neurodegeneration. Here, we use novel imaging techniques to determine whether macro- and micro-structural changes can be detected across the whole-brain in the same cohort. Methods: 62 premanifest HD (PreHD) and 61 controls from the HD Young Adult Study (HD-YAS) were included. Grey and white matter volume, diffusion weighted imaging (DWI) measures of white matter microstructure, multiparametric maps (MPM) estimating myelin and iron content from magnetization transfer (MT), proton density (PD), longitudinal relaxation (R1) and effective transverse relaxation (R2*), and myelin g-ratio were examined. Group differences between PreHD and controls were assessed; associations between all imaging metrics and disease burden and CSF neurofilament light (NfL) were also performed. Volumetric and MPM results were corrected at a cluster-wise value of familywise error (FWE) 0.05. Diffusion and g-ratio results were corrected via threshold-free cluster enhancement at FWE 0.05. Findings: We showed significantly increased R1 and R2*, suggestive of increased iron, in the putamen, globus pallidum and external capsule of PreHD participants. There was also a significant association between lower cortical R2*, suggestive of reduced myelin or iron, and higher CSF NfL in the frontal lobe and the parieto-occipital cortices. No other results were significant at corrected levels. Interpretation: Increased iron in subcortical structures and the surrounding white matter is a feature of very early PreHD. Furthermore, increases in CSF NfL were linked to microstructural changes in the posterior parietal-occipital cortex, a region previously shown to undergo some of the earliest cortical changes in HD. These findings suggest that disease related process are occurring in both subcortical and cortical regions more than 20 years from predicted disease onset.http://www.sciencedirect.com/science/article/pii/S2352396421000591Huntington's diseaseMRIMicrostructureIronMyelin